Advertisement

Headaches in the emergency department –a survey of patients’ characteristics, facts and needs

  • Alberto Doretti
  • Irina Shestaritc
  • Daniela Ungaro
  • John-Ih Lee
  • Loukas Lymperopoulos
  • Lili Kokoti
  • Martina Guglielmetti
  • Dimos Dimitrios Mitsikostas
  • Christian LamplEmail author
  • on behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)
Open Access
Research article

Abstract

Background and aim

Headache is very often the cause for seeking an emergency department (ED). However, less is known about the different diagnosis of headache disorders in the ED, their management and treatment. The aim of this survey is to analyse the management of headache patients in two different ED in Europe.

Methods

This retrospective survey was performed from September 2018 until January 2019. Patients were collected from the San Luca Hospital, Milan, Italy and the Ordensklinikum Barmherzige Schwestern, Linz, Austria. Only patients with a non-traumatic headache, as the primary reason for medical clarification, were included. Patients were analysed for their complexity and range of examination, their diagnoses, acute treatment and overall efficacy rate.

Results

The survey consists of 415 patients, with a mean age of 43.32 (SD ±17.72); 65% were female. Technical investigation was performed in 57.8% of patients. For acute treatment non-steroidal-anti-inflammatory drugs (NSAIDs) were the most used, whereas triptans were not given. A primary headache disorder was diagnosed in 45.3% of patients, being migraine the most common, but in 32% of cases the diagnosis was not further specified. Life-threatening secondary headaches accounted for less than 2% of cases.

Conclusions

The vast majority of patients attending an ED because of headache are suffering from a primary headache disorder. Life-threatening secondary headaches are rare but seek attention. NSAIDs are by far the most common drugs for treating headaches in the ED, but not triptans.

Keywords

Headache Emergency department Primary headache Migraine Secondary headache 

Abbreviations

CT

Computer Tomography

ECG

Electrocardiogram

ED

Emergency Department

ENT

Ear-Nose-Throat

ICHD III

International Classification of Headache Disorders, 3rd edition

MRI

Magnet Resonance Imaging

N/A

Non applicable

NSAIDs

Non-steroidal-anti-inflammatory-Drugs

PGI

Patients Global Impression,

SAH

Subarachnoid haemorrhage

TACs

Trigeminal autonomic cephalalgias

TTH

Tension-type headache

Introduction

Headaches are one of the most challenging complaints in the emergency department (ED) accounting for 1–4% of all ED visits [1, 2, 3, 4]. Headache types, diagnostic procedures and acute treatment may vary in different EDs throughout countries, depending on the catchment area, specific departments of the hospital, structure of their particular ED, in-house protocols and local medical staff. In addition, clinicians in the ED are busy, usually with a limited time setting and in general facing two challenges: filtering patients who need further diagnostic evaluation, including neuroimaging and lumbar puncture in specific cases, as well as the aim of headache relief by adequate treatment. Life-threatening conditions presenting with headache embrace cerebrovascular, brain mass effect and inflammatory-infection pathologies mainly, yet rare compared to primary headache disorders. To screen patients for a plausible secondary headache in ED, physicians should consider the suggested “red flag” symptoms in patients presenting with headache [5]. Red flag symptoms are numerous and do not include exclusively neurological signs. Moreover, potential co-morbidities, specific headache history and individualised patient characteristics should be considered. In a few studies exploring the frequency of secondary headaches in ED, approximately 5% of patients with severe headaches had a secondary headache [6], some of them life-threatening or severe disabling [7]. However, the majority of patients had a benign diagnosis. Published data about headache patients in the ED, their diagnoses and management are rare, especially when comparing different countries.

In this current study we provide results on characteristics and management of non-trauma headache patients in the ED of two different European Union cities. These results were compared with the so far published surveys and critically discussed.

Methods

This cross-sectional cohort study was performed retrospectively from September 2018 until January 2019. Patients were collected from two hospitals in Europe: the San Luca Hospital of Istituto Auxologico Italiano, Milan, Italy and the Ordensklinikum Barmherzige Schwestern, Linz, Austria.

The San Luca Hospital in Milan is a Scientific Institute for Hospitalisation and Care including a non-profit organisation for biomedical and high specialization hospital treatment. This ED consists of 3 different examination rooms. A cardiologist, nurses and other paramedics are in charge and a neurologist on call. In 2018, 11.073 patients visited the ED and the physicians examined 923 cases (mean) per month.

The Ordensklinikum Barmherzige Schwester is a general hospital in Linz with 663 beds and 17 different departments and institutes. In the ED general practitioners, internal medicine physicians, neurologists and nurses are working in an interdisciplinary setting. The hospital has 8 specific admission days per month. In 2018, 26.978 patients visited the ED and the physicians examined 207 cases (mean) per month.

The study conformed to the revised ethical principles of the Helsinki declaration and the Codex rules and guidelines for research. It is based on patients who participated in the inpatient assessment and treatment program in the both ED. During their first appointment all patients participating in the survey provided written informed consent to use their data for the quality control, and to publish the data in anonymized form as part of the quality control process. Therefore, an ethics approval was not obtained for the present analysis.

Patients were eligible for inclusion if they presented to the ED with an acute or longer lasting, disabling non-traumatic headache of any potential cause. The headaches were characterized with descriptive statistics calculated for patient demographic, clinical findings, investigations, and ED diagnosis. As analyses were considered exploratory, no formal adjustment for multiple comparisons was performed. In an exploratory analysis, both hospitals were compared, using the chi-square test, Fisher’s exact test, Student t-test, or Wilcoxon rank-sum test as appropriate. Statistical significance was set at a < 0.05 (two-sided). Patients were analysed for their complexity and range of examination, their diagnoses, acute treatment intervention and overall efficacy rate at discharge (Patients Global Impression (PGI) Q:” Have you been satisfied with the examination and treatment regime - Yes/No?”).

Results

Demographics

The survey consists of 415 patients (184 patients from the San Luca Hospital and 231 patients from the Ordensklinikum Barmherzige Schwestern, Linz). 268 (65%) were female and 147 (35%) male, with a mean age of 43.32 (SD ±17.72; ranged from 15 to 96 years). Overall, non-traumatic headache accounted for 3.2% of the total ED visits (3.5% in Linz and 2.9% in Milan), being disproportionately more females (65% vs. 35%, p = .001). Eighty-two of all patients (19.8%) presented vomiting as a concomitant symptom. Five patients (2.7%) had a history of non-headache specific trauma in their history (Table 1).
Table 1

Demographics and patients characteristics

 

Both hospitals

n = 415 (%)

Linz, Austria

n = 231 (%)

Milan, Italy

n = 184 (%)

p-value

Age (y), M, SD,

43.32 ± 17.72

42.37 ± 17.74

51.26 ± 16.46

<.001

(range)

(15–96)

(15–96)

(15–85)

 

Female

268 (65.0)

141 (39.0)

126 (68.5)

.000

Male

147 (35.0)

90 (61.0)

58 (31.5)

.000

Mean time since onset (in hours)

 

20.71 ± 88.31 (range 0–1095 h)

175.56 ± 476.72 (range 0.33–4120 h)

.000

Neurological Exam

301 (72.5)

197 (85.3)

104 (56.5)

.000

Technical investigation

 Head CT

221 (53.2)

109 (47.2)

112 (60.96)

.007

 Brain MRI

7 (1.7)

4 (1.7)

3 (1.6)

.445

 Angio-CT

12 (2.9)

4 (1.7)

8 (4.3)

.144

 Lumbar puncture

5 (1.2)

2 (0.9)

3 (1.6)

.659

 Facial TC Scan

6 (1.4)

0 (0)

6 (1.6)

 

 EEG

1 (0.2)

0 (0)

1 (0.3)

 

 Cervical RX

1 (0.2)

0 (0)

1 (0.3)

 

Other examination

 Blood test

333 (80.0)

163 (58.2)

170 (46.1)

 

 ECG

225 (54.0)

42 (15.0)

183 (49.7)

 

 ENT examination

5 (1.2)

5 (1.8)

0 (0)

 

Ophthalmological examination

4 (1.0)

4 (1.2)

0 (0)

 

ECG Electrocardiogram, ENT Ear-Nose-Throat, CT Computer Tomography, MRI Magnet

Work-up and treatment

Neurological examination was performed in 301 of patients (72.5%), statistically significant more in Linz than in Milan ((197, 85.3% vs 104; 56.5%, p = .000). Technical investigation was performed in 253 patients (60.9%); 221 patients (53.2%) had a non-contrast cranial CT, 12 patients (2.9%) received a cranial CT with additional CT angiography and 7 patients (1.7%) underwent a brain MRI. A lumbar puncture was performed in five patients (1.2%). Thirty-five patients (8.4%) were admitted to the local neurological department for further investigations, because they had focal neurological symptoms. Other examinations consist of blood test (n = 333; 80%), ECG (n = 225; 54%), ENT and opthalmological examination were done in 9 patients (2.2%).

For acute treatment (n=408) non-steroidal-anti-inflammatory drugs were given in 237 patients (58.0%), acetaminophen in 58 patients (14.2%), 2 patients (0.5%) received corticosteroids and 94 (23.0%) received other drugs (including aspirin, antiemetics, metamizol, paracetamol). Triptans were not given in any patients. Further therepeutic recommendations at discharge were shown in Table 2. The overall efficacy rate (PGI) was satisfactory in 195 patients (47.4%). A therapeutic recommendation at discharge was given in 401 patients (96.6%).
Table 2

Therapeutic procedures

 

Acute therapy in the ED

Therapeutic recommendations at discharge

 

All

n = 408 (%)

Linz, Austria

n = 227 (%)

Milan, Italy

n = 181 (%)

All

n = 401 (%)

Linz, Austria

n = 231 (%)

Milan, Italy

n = 170 (%)

NSAIDs

237 (58.0)

142 (62.5)

95 (52.5)

164 (40.9)

102 (44.1)

62 (36,5)

Steroids

2 (0.5)

1 (0.4)

1 (0.5)

0 (0)

0 (0)

0 (0)

Triptans

0 (0)

0 (0)

0 (0)

9 (2.2)

3 (1.3)

6 (3.5)

Acetaminophen

58 (14.2)

18 (7.9)

40 (22.1)

50 (12.5)

28 (12.1)

22 (12.9)

Others

94 (23.0)

53 (23.3)

41 (22.7)

155 (38.7)

75 (32.5)

80 (4.7)

missing data

17 (4.1)

17 (7.4)

0 (0)

23 (5.7)

0 (0)

23 (13.5)

ED Emergency department, NSAIDs Non-steroidal anti-inflammatory drugs, N/A Non applicable

Diagnosis

The final diagnoses, according to the ICHD 3 classification of headache disorders [8] are shown in Table 3. A primary headache was found in 188 patients (45.3%), while 90 patients (21.7%) had a secondary headache, a trigeminal neuralgia was diagnosed in 4 patients (1.0%). Headache diagnosis was not further specified in 133 patients (32.0%).
Table 3

Final diagnosis at discharge

Type of headache

All Hospitals

n = 415 (%)

Linz

n = 231(%)

Milan

n = 184(%)

X2

p-value

Primary Headache

 Unknown cause

  („not better specified“)

133 (32.0)

92 (42.4)

41 (22.2)

14.47

<.001

  Migraine

110 (26.5)

59 (25,5)

61 (33,2)

2.886

.102

  TTH

68 (16.4)

44 (19.0)

24 (13.0)

2.695

.110

  TTH + migraine

10 (2.4)

10 (2.4)

0 (0)

8.162

.003

  TACs

0 (0)

0 (0)

0 (0)

  

Secondary Headache

 Sinusitis

18 (14.3)

15 (6.5)

3 (1.6)

5.838

.016

 Hypertension

33 (7.95)

12 (5.2)

21 (11.4)

5.410

.027

 SAH

5 (1.2)

1 (0.4)

4 (2.2)

2.608

.176

 Meningitis or encephalitis

1 (2.4)

0 (0)

1 (0.3)

1.258

.443

Neuralgia

 Trigeminal neuralgia

4 (0.96)

2 (0.9)

2 (1.1)

.052

1

TTH Tension-type headache, TACs Trigeminal autonomic cephalalgias, SAH Subarachnoid haemorrhage

287 (69.1%) were discharged at home, 84 (20.2%) has to be transferred to the ED short-stay unit for further observation. Thirty-five patients (8.4%) were admitted to the neurological department for additional investigation.

Discussion

In our current analysis of patients visited the ED because of headache, in both hospitals migraine has been reported to be the most common cause (26%) of primary headaches. Similar migraine diagnosis rate in the EDs was found in a cross-sectional Australian study [10]. In contrast to that, a recent published, large epidemiological US trial showed over a 10-year period of observation, that migraine was present in 63.5% of all headache presentations in an ED [7]. One possible explanation for this major difference comes up from the American Migraine Study published in 1998: Lipton and colleagues estimated that only 66% of migraine sufferers had ever consulted a doctor for headache [9], and one of the major causes for this is an insufficient outpatient care and/or low consultation rates. Therefore more headache sufferers make a claim on ED to seek help for their burden. Other major findings, as the predominance of female headache patients in the ED, are in line with previous observations in the United States of America [6], in Australia [10], as well as in Brazil [11]. Compared to lower percentages (14.5% or 38%) found in previous studies [4, 10] in our survey 53% patients received CT scans in the ED.

Vomiting was a frequent observation in headache ED patients, which is explained by the fact that vomiting is one of the cardinal symptoms of migraine, and migraine is the most common cause of primary headaches in the ED [4, 10]. Likewise, another study has reported a higher percentage of 31.7% [10]. The percentage of life threatening secondary headache diagnoses (bleedings, meningitis/encephalitis) in our study was below 2%, which is also in agreement (< 3%) with previous studies published [4, 10].

About 32% of the headaches in this study were simply labelled as “headache” without a more specific ICHD 3 diagnosis [8]. This is lower than the 44% reported by Chu and colleagues [10] and similar to the 36% reported by Friedman and colleagues [12], who conducted detailed structured patient interviews with the assistance of trained research associates. However, the ratio of headache cases not further specified remains high in our survey, outside the expected limits. A possible reason may be related to the multi-professional staffing of the two hospitals. General practitioners, internal medicine physicians, cardiologists, and neurologists work together to provide a multidisciplinary approach for these patients; therefore not all headache patients were seen and managed by neurologists, or by a headache specialist. Furthermore, the physicians must be able to address the patient’s need for pain management in a very short and intense timeframe and exclude simultaneously any possibility of a life threatening illness. The challenge in the busy setting of an ED is to decide within a limited amount of time, which patient is in need of immediate further diagnostic work up in order to exclude any secondary, dangerous headaches, that might have serious and irreversible health consequences, if diagnosis and treatment are delayed.

Surprisingly, 94% of our patients received non-specific simple analgesic drugs for acute headache therapy, but none received a triptan, although they were available in both ED. For patients presenting de novo to an ED for management of migraine, emergency clinicians clearly have a broad armamentarium of therapeutic options. In these cases, we speculate emergency clinicians might choose to use non-specific simple analgesic drugs instead of triptans for one of the following reasons: (i) they believe that non-specific simple analgesic drugs are effective and appropriate for the acute treatment of migraine; (ii) they are concerned about adverse events of triptans; (iii) they are not sufficiently familiar with triptans; (iv) they prefer a treatment parentally administrated for faster efficacy and/or because of vomiting (only sumatriptan is available in this formulation); (iv) ED were not supplied with any triptan. However, triptans were prescribed in 9 patients (2%) at discharge. Reasons for the low application of triptans should be investigated in further studies. This could be of special interest for care managers, because previously published data revealed that patients who received triptans had the shortest median length of stay in the ED [13].

In our setting 53% of patients had a CT head scan, which is very much higher than in other surveys [5, 10, 11]. Reasons for that may be complex. Physicians often work under the pressure of time constraints, and initial assessment, including SNNOOPS 10 list [14] can be difficult, especially in patients with pre-existing neurological or psychological conditions. Studies have reported difficulties in making a definite headache diagnosis in the setting of ED [15, 16, 17] without any CT scan of the brain. However, a careful history and physical examination remain the most important parts of the assessment of the headache patients in order to identify high-risk patients and to exclude any secondary headache, that, if left without treatment, could have disastrous effects on the patient’s health [7, 10]. Patients who have one or more high-risk historical features or examination findings are considered to have a life-threatening condition requiring urgent diagnostic work-up [18, 19]. Red flag symptoms include neurological signs or symptoms (confusion, seizure, altered mental status, loss of consciousness, asymmetric reflexes, focal neurologic deficits or visual deficits), meningism, fever, sudden and severe onset of the headache or change in the characteristics of a known headache, advanced age (onset after 50 to 65 years), pregnancy or puerperium, coagulopathy, neoplasm history, positional headache, headache precipitated by sneezing, coughing or exercise, painful-eye with autonomic features, posttraumatic onset of headache, painkiller overuse or new drug at onset of headache and any systemic disease including HIV infection and any immunosuppressed state in general [6, 10, 14]. The European Headache Federation consensus reports the reasons and headache cases that may need technical investigation, as well as the required tests [5].

Study limitations and strengths

There are several limitations that should be addressed. First, the study was a retrospective data analysis and all clinical data were collected by the treating physician and not by dedicated trained headache experts. Second, the treating physicians did not record data. Eligibility was not verified, nor was missing cases specifically sought. Systematic selection bias is possible, but unlikely given cases were enrolled in the ED 24 h per day by many clinicians across both sites. For the data collection, questions on clinical history were probably different in both centres, as there was no uniform and standardised questionnaire. Whether missing data may bias the results will depend on whether the data were missing at random or not. The latter could be problematic. On the other hand, this is the first survey conducted in Europe reporting real word data for the management of headache in an ED setting. This information may trigger relevant organisations and health care designers to improve care delivered in ED.

Conclusion

Patients with non-traumatic headache as the primary presenting symptom in the ED are more often women than men. The majority of headache patients in the ED had primary headaches with migraine being the most frequent diagnosis. Life threatening secondary headaches, including SAH and meningitis/encephalitis, were rare, accounting for less than 2% of the patients. NSAIDs and acetaminophen were the most commonly used symptomatic therapy of headaches, while triptans were not used in the ED.

Notes

Acknowledgements

We wish to thank the patients participating in our inpatient assessment and treatment program. We are grateful to Salvatore Sarubb for performing statistical analyses.

Authors’ contributions

All Authors equally contributed to the review. AD, IS, DU, J-IL, LL, LK, GF, MG are Junior Fellows of EHF-SAS. CL and DDM are Senior Fellows of EHF-SAS. All authors read and approved the final manuscript.

Funding

There was no funding for the present study.

Ethics approval and consent to participate

The study conformed to the revised ethical principles of the Helsinki declaration and the Codex rules and guidelines for research. The present study is based on patients who participated in the inpatient assessment and treatment program in the Emergency department San Luca Hospital of Istituto Auxologico Italiano, Milan, Italy and the Ordensklinikum Barmherzige Schwestern, Linz, Austria. During their first appointment all patients participating in the survey provided written informed consent to use their data for the quality control, and to publish the data in anonymized form as part of the quality control process. Therefore, an ethics approval was not obtained for the present analysis.

Consent for publication

Written informed consent was obtained from the patient for the publication of this report.

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    Locker T, Mason S, Rigby A (2204) Headache management—are we doing enough? An observational study of patients presenting with headache to the emergency department. Emerg Med J 21:327–332CrossRefGoogle Scholar
  2. 2.
    Leicht MJ (1980) Non-traumatic headache in the emergency department. Ann Emerg Med 9:404–409CrossRefGoogle Scholar
  3. 3.
    Ramirez-Lassepas M, Espinosa CE, Cicero JJ, Johnston KL, Cipolle RJ, Barber DL (1997) Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Arch Neurol 54:1506–1509CrossRefGoogle Scholar
  4. 4.
    Barton CW (1994) Evaluation and treatment of headache patients in the emergency department: a survey. Headache 34:91–49CrossRefGoogle Scholar
  5. 5.
    Mitsikostas DD, Ashina M, Craven A, Diener HC, Goadsby PJ, Ferrari MD, Lampl C, Paemeleire K, Pascual J, Siva A, Olesen J, Osipova V, Martelletti P, on behalf of EHF (2016) European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain 17:5CrossRefGoogle Scholar
  6. 6.
    Goldstein JN, Camargo CA Jr, Pelletier AJ, Edlow JA (2006) Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia 26(6):684–690CrossRefGoogle Scholar
  7. 7.
    Tabatabai RR, Swadron SP (2016) Headache in the emergency department: avoiding misdiagnosis of dangerous secondary causes. Emerg Med Clin North Am 34:695CrossRefGoogle Scholar
  8. 8.
    Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211CrossRefGoogle Scholar
  9. 9.
    Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American migraine study. Headache 38:87–96CrossRefGoogle Scholar
  10. 10.
    Chu KH, Howell TE, Keijzers G, Furyk JS, Eley RM, Kinnear FB, Thom O, Mahmoud I, Brown AF (2017) Acute headache presentations to the emergency department: a state wide cross-sectional study. Acad Emerg Med 24(1):53–62CrossRefGoogle Scholar
  11. 11.
    Bigal M, Bordini CA, Speciali JG (2000) Headache in an emergency room in Brazil. Sao Paulo Med J/Rev Paul Med 118(3):58–62CrossRefGoogle Scholar
  12. 12.
    Friedman Friedman BW, Hochberg ML, Esses D, Grosberg B, Corbo J, Toosi B, Meyer RH, Bijur PE, Lipton RB, Gallagher EJ (2007) Applying the international classification of headache disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med 49:409–419CrossRefGoogle Scholar
  13. 13.
    Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher AJ (2015) Current management of migraine in US emergency departments: An analysis of the National Hospital Ambulatory Medical Care Survey. Cephalalgia 35(4):301–309CrossRefGoogle Scholar
  14. 14.
    Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, Hansen JM, Sinclair AJ, Gantenbein AR, Schoonman GG (2019) Red and orange flags for secondary headaches in clinical practice: SNNOOP 10 list. Neurology 92(3):134–144CrossRefGoogle Scholar
  15. 15.
    Cortelli P, Cevoli S, Nonino F, Baronciani D, Magrini N, Re G, De Berti G, Manzoni GC, Querzani P, Vandelli A, Multidisciplinary Group for Nontraumatic headache in the Emergency Department (2004) Evidence-Based Diagnosis of Nontraumatic in the Emergency Department: a Consensus Statement on Four Clinical Scenarios. Headache 44:587–559CrossRefGoogle Scholar
  16. 16.
    Barton C (1993) Evaluation and treatment of headache patients in the emergency department: a survey. Headache 34:91–94CrossRefGoogle Scholar
  17. 17.
    Friedman BW, Grosberg BM (2009) Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am 27:71–87CrossRefGoogle Scholar
  18. 18.
    Nye BL, Ward TN (2015) Clinic and emergency room evaluation and testing of headache. Headache 55(9):1301–1308CrossRefGoogle Scholar
  19. 19.
    Levin M (2015) Approach to the workup and Management of Headache in the emergency department and inpatient settings. Semin Neurol 35(6):667–674CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Alberto Doretti
    • 1
  • Irina Shestaritc
    • 2
  • Daniela Ungaro
    • 1
  • John-Ih Lee
    • 3
  • Loukas Lymperopoulos
    • 4
  • Lili Kokoti
    • 5
  • Martina Guglielmetti
    • 6
    • 7
  • Dimos Dimitrios Mitsikostas
    • 8
  • Christian Lampl
    • 9
    Email author
  • on behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)
  1. 1.Department of Neurology-Stroke Unit and Laboratory of NeuroscienceIstituto Auxologico ItalianoMilanItaly
  2. 2.Department of NeurorehabilitationYaroslavl regional clinical hospital of War VeteransYaroslavlRussian Federation
  3. 3.Department of Neurology, Medical FacultyHeinrich-Heine-UniversityDuesseldorfGermany
  4. 4.80th Battalion of Medical CorpsGeneral Ioannis Makrygiannis CampKosGreece
  5. 5.General Hospital of GrevenaGrevenaGreece
  6. 6.Regional Referral Headache CentreSant’ Andrea HospitalRomeItaly
  7. 7.Department of Medical, Surgical and Experimental SciencesUniversity of SassariRomeItaly
  8. 8.1st Neurology Department, Aeginition Hospital, Medical SchoolNational and Kapodistrian University of AthensAthensGreece
  9. 9.Headache Medical Center LinzOrdensklinikum Barmherzige SchwesternLinzAustria

Personalised recommendations